Infection and glomerulonephritis

被引:0
作者
Saraladevi Naicker
June Fabian
Sagren Naidoo
Shoyab Wadee
Graham Paget
Stewart Goetsch
机构
[1] University of the Witwatersrand,Division of Nephrology
来源
Seminars in Immunopathology | 2007年 / 29卷
关键词
Infections; Glomerulonephritis; Human immunodeficiency virus; Streptococcal; Hepatitis B virus; Hepatitis C virus;
D O I
暂无
中图分类号
学科分类号
摘要
Glomerular injury, occurring either as primary glomerular disease or as part of a systemic disease process, is usually a result of immune-mediated mechanisms. The morphologic reaction pattern has a diverse spectrum of appearance, ranging from normal by light microscopy in minimal change disease to crescentic forms of glomerulonephritis, with conspicuous disruption of the normal glomerular morphology. The mechanisms of glomerular immune deposit formation include trapping of circulating antigen–antibody complexes and the in situ formation of immune complexes within the glomerulus. While the majority of postinfectious immune-complex-mediated glomerulonephritides are believed to result from the deposition of circulating antigen–antibody complexes, preformed outside of the kidney and secondarily deposited in the kidney, the notion of forming in situ antigen–antibody complexes to either planted antigens or to integral structural components of the glomerulus, through “cross-reacting” autoimmune reactions, is gaining popularity in a variety of forms of glomerulonephritides. Patients with HIV infection may develop a spectrum of renal pathology, the glomerular manifestations of which include both antigen–antibody complex and nonimmune-complex-mediated pathogenetic mechanisms. Similarly, patients with Streptococcal infections, Hepatitis B virus, or Hepatitis C virus infection may develop a spectrum of glomerulonephritides, which are predominantly immune-complex-mediated. Therapy for glomerular diseases due to HIV, hepatitis B, or C virus infections remains a challenge.
引用
收藏
页码:397 / 414
页数:17
相关论文
共 208 条
  • [91] Nordstrand A( (1996))Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis Kidney Int 49 335-343
  • [92] Nordstrand A(1998)Hepatitis B virus-associated nephropathy in black South African children Pediatr Nephrol 12 479-484
  • [93] Norgren M(1991)Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults Kidney Int Suppl 35 S40-S45
  • [94] Holm SE( (1991))Membranous nephropathy related to hepatitis B virus in adults N Engl J Med 324 1457-1463
  • [95] Glurich I( (1990))The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia Nephron 54 12-17
  • [96] Couser WG( (2005))Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication Ann Pharmacother 39 573-389
  • [97] Han SH( (2002))Treatment of hepatitis B virus-associated nephropathy in black children Pediatr Nephrol 17 393-117
  • [98] Combes B( (1997))Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon Am J Nephrol 17 112-230
  • [99] Levy M(1995)Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon Kidney Int 47 225-788
  • [100] Chen N(2006)Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis Aliment Pharmacol Ther 24 781-1758